Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1

Human Molecular Genetics

Volumn 17, Issue 4, 2008, Pages 602-616

  Weihofen, Andreas ^a   Ostaszewski, Beth ^a   Minami, Yasufumi ^b   Selkoe, Dennis J ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MAEBASHI INSTITUTE OF TECHNOLOGY   (Japan)

^c HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN 37; CHAPERONE; HEAT SHOCK PROTEIN 90; PARKIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE INDUCED KINASE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN; CELLULAR DISTRIBUTION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; IN VITRO STUDY; MASS SPECTROMETRY; MITOCHONDRION; NERVE CELL CULTURE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ANIMALS; BASE SEQUENCE; CELL CYCLE PROTEINS; CELL LINE; CERCOPITHECUS AETHIOPS; CHAPERONINS; COS CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOCHONDRIA; MOLECULAR WEIGHT; MULTIPROTEIN COMPLEXES; MUTATION; ONCOGENE PROTEINS; PARKINSONIAN DISORDERS; PLASMIDS; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SOLUBILITY; SUBCELLULAR FRACTIONS; TANDEM MASS SPECTROMETRY; TRANSFECTION; UBIQUITIN-PROTEIN LIGASES;

EID: 38849155699     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm334     Document Type: Article

References (34)

1. Hardy, J., Cai, H., Cookson, M.R., Gwinn-Hardy, K. and Singleton, A. (2006) Genetics of Parkinson's disease and parkinsonism. Ann. Neurol. 60, 389-398.
2. Klein, C. and Schlossmacher, M.G. (2006) The genetics of Parkinson disease: Implications for neurological care. Nat. Clin. Pract. Neurol.. 2, 136-146.
3. Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A.R., Healy, D.G. et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science, 304, 1159-1160.
4. Valente, E.M., Salvi, S., Ialongo, T., Marongiu, R., Elia, A.E., Caputo, V., Romito, L., Albanese, A., Dallapiccola, B. and Bentivoglio, A.R. (2004) PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann. Neurol., 56, 336-341.
5. Beilina, A., Van Der Brug, M., Ahmad, R., Kesavapany, S., Miller, D.W., Petsko, G.A. and Cookson, M.R. (2005) Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc. Natl Acad. Sci. USA, 102 5703-5708.
6. Silvestri, L., Caputo, V., Bellacchio, E., Atorino, L., Dallapiccela, B., Valente, E.M. and Casari, G. (2005) Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum. Mol. Genet., 14, 3477-3492.
7. Sim, C.H., Lio, D.S., Mok, S.S., Masters, C.L., Hill, A.F. Culvenor, J.G. and Cheng, H.C. (2006) C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Hum. Moll Genet., 15 3251-3262.
8. Kubo, S., Halton, N. and Mizuto, Y. (2006) Recessive Parkinson's disease. Mov. Disord., 21, 885-893.
9. Park. J., Lee, S B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.M, et al. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature, 441, 1157-1161.
10. Yang, Y., Gehrke, S., Imai, Y., Huang, Z., Ouyang, Y., Wang, J.W., Yang, L., BW, M.F., Vogel, H. and Lu, B. (2006) Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc. Natl Acad. Sci. USA, 103, 10793-10798.
11. Clark, I.E., Dodson, M.W., Jiang, C., Can, J.H., Huh, J.R., Seol, J.H., Yoo,, S.J., Hay, B.A. and Guo, M. (200) Drosophila pink1 is required for mitochondrial function and interacts genetically wit parkin. Nature 441, 1162-1166.
12. Deng, H., Jankovic, J., Guo, Y., Xie, W. and Le, W. (2005) Small interfering RNA targeting the PINK1-induces apoptosis in dopaminergic cells SH-SY5Y. Biochem. Biophys. Res. Commun., 337, 1133-1138.
13. MacKeigan, J.P., Murphy, L.O. and Blenis, J. (2005) Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis,and chemoresistance. Nat. Cell. Biol., 7, 591-600.
14. Petit, A., Kawarai, T., Paitel, E., Sanjo, N., Maj, M., Scheid, M., Chen, F., Gu, Y., Hasegawa, H., Salehi-Rad, S. et al. (2005) Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J. Biol. Chem., 280, 34025-34032.
15. Pridgeon, J.W., Olzmann, J.A., Chin, L.S. and Li, L. (2007) PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1. PLoS Biol., 5, e172.
16. Tang, B., Xiong, H., Sun, P., Zhang, Y., Wang, D., Hu, Z., Zhu, Z., Ma, H., Pan, Q., Xia, J.H. et al. (2006) Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease. Hum. Mol. Genet., 15, 1916-1925.
17. Gandhi S., Muqit, M.M., Stanyer, L., Healy, D.G., Abou-Sleiman, P.M., Hargreaves, I., Heales, S., Ganguly, M., Parsons, L., Lees, A.J. et al. (2006) PINK1 protein in normal human brain and Parkinson's disease. Brain, 129, 1730-1731.
18. Muqit, M.M., Abou-Sleiman, P.M., Saurin, A.T. Harvey K., Gandhi, S., Deas, E., Eaton, S., Payne Smith, M.D., Vennef, K., Matilla, A. et al. (2006) Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J. Neurochem., 98, 156-164.
19. Caplan, A.J., Mandal, A.K. and Theodoraki, M.A. (2007) Molecular chaperones and protein kinase quality control. Trends Cell. Biol., 17, 87-92.
20. Sato, S., Fujita, N. and Tsuruo, T. (2000) Modulation of Akt kinase activity by binding to Hsp90. Proc. Natl Acad. Sci. USA, 97, 10832-10837.
21. Auluck, P.K. and Bonini, N.M. (2002) Pharmacological prevention of Parkinson disease in Drosophila. Nat. Med., 8, 1185-1186.
22. Young, T.C., Hoogenraad, N.J. and Hartl, F.U. (2003) Molecular chaperones Nsp90 and Hsp70 deliver prcproteins to the mitochondrial. import receptor Tom70. Cell, 112, 41-50.
23. Meyer, P., Prodromou, C., Hu, B., Vaughan, C., Roe, S.M., Panaretou, B., Piper, P. W. and Pearl, L,H. (2003) Structural and functional analysis of the middle segment of hsp90: Implications for ATP hydrolysis and client protein and cochaperone interactions. Mol Cell, 11, 647-658.
24. Hadden, M.K. Lubbers, D.J. and Blagg, B.S. (2006) Geldanamycin, radicicol, and chimeric inhibitors of the Hsp90 N-terminal ATP binding site. Curr. Top. Med. Chem., 6, 1173-1182.
25. Terasawa, K. and Minami, Y. (2005) A client-binding site of Cdc37. FEBS J., 272, 4684-4690.
26. MacLean, M. and Picard, D. (2003) Cdc37 goes beyond Hsp90 and kinases. Cell Stress Chaperones, 8, 114-119.
27. Ibanez, P., Lesage, S., Lohmann, E., Thobois, S., De Michele, G., Borg, M., Agid, Y., Durr, A. and Brice, A. (2006) Mutational analysis of the PINK1 gene in early-onset parkinsonism in: Europe and North Africa. Brain, 129, 686-694.
28. Tan, J.M. and Dawson, T.M. (2006) Parkin blushed by PINK1. Neuron, 50, 521-529.
29. Grammatikakis, N., Lin, J.H., Grammatikakis, A., Tsichlis, P.N. and Cochran, B.H. (1999) p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function. Mol. Cell Biol., 19, 1661-1672.
30. Martoglio, B. and Dobberstein, B. (1998) Signal sequences: More than just greasy peptides. Trends Cell. Biol., 8, 410-415.
31. Chan, D.C. (2006) Mitochondrial fusion and fission in mammals. Annu. Rev. Cell. Dev. Biol., 22, 79-99.
32. Jiang, H., Ren, Y., Zhao, J. and Feng, J. (2004) Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis. Hum. Mol. Genet., 13, 1745-1754,
33. Lo Bianco, C., Schneider, B.L., Bauer, M., Sajadi, A., Brice, A., Iwatsubo, T. and Aebischer, P. (2004) Lentiviral vector delivery of parkin prevents dopaminergic degdneration in an alpha-synuclein rat model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 101 17510-17515.
34. Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-piotein ligase. Nat. Genet., 25, 302-305.